Lifevantage Corp (LFVN) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lifevantage Corp  (NASDAQ: LFVN)


Lifevantage's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lifevantage's ROI in the first quarter of 2026?
Lifevantage Corp achieved a return on average invested assets (ROI) of 6.51 % in its first quarter of 2026, which is below Lifevantage's average return on investment, which stands at 22.45%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 42 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 426 to 586.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
I. Quarter		 (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter
Y / Y Investment Change TTM -3.43 % -0.56 % 5.31 % 10.89 % 11.07 %
Y / Y Net Income Change TTM -73.15 % -48.27 % -26.69 % 79.62 % 454.98 %
Investment (TTM) in Millions 41 42 42 42 43
Return On Investment (TTM) 6.51 % 12.02 % 13.4 % 18.04 % 23.41 %
LFVN's Overall Ranking # 586 # 426 # 242 # 233 # 264
Seq. Investment Change TTM -0.97 % -1.66 % -1.51 % 0.68 % 1.98 %
Seq. Net Income Change TTM -46.35 % -11.82 % -26.82 % -22.44 % 3.36 %
Net Income (TTM) in Millions 3 5 6 8 10

LFVN Company Profile >> Back to LFVN Roi Comparisons >> See Annual LFVN Return On Investment



Return On Investment LFVN's Ranking
Within: No.
Industry # 18
Sector # 43
Overall # 586

Return On Investment Statistics
High Average Low
78.47 %
22.45 %
-1.82 %
(Jun 30 2012)   (Mar 31 2023)







Financial Statements
Lifevantage's I. Quarter Investments $ 41 Millions LFVN's Balance sheet
Lifevantage's I. Quarter Income $ 0 Millions Quarterly LFVN's Income Statement
LFVN's Income by Division See LFVN's Income by Division


LFVN Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 42 45 38 47 45
Y / Y Investment Growth -6.39 % 17.77 % -18.33 % 3.42 % -15.98 %
Net Income in Millions 5 10 3 3 3
Y / Y Net Income Growth -48.27 % 233.84 % 15.63 % -18.59 % -75.8 %
Annual Return On Investment 12.11 % 21.92 % 7.73 % 5.46 % 6.94 %


Annual Roi Comment
In the fiscal year 2026 ROI decreased relative to the previous year to 12.11 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LFVN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LFVN's Competitors
Subscribers only: Roi for Lifevantage's Suppliers
Subscribers only: Return On Investment for LFVN's Customers

Other Ratios
LFVN's Roa LFVN's Inventory Turnover Ratio LFVN's Growth Rates LFVN's Dividend Statistics
LFVN's Profitability Ratios LFVN's Asset Turnover Ratio LFVN's Dividend Growth
LFVN's Roe LFVN's Valuation Ratios LFVN's Financial Strength Ratios LFVN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %

Date modified: 2026-11-11T02:40:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.